AnneEdenEvinsMD

William Cox Family Associate Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School and founding director of the Center for Addiction Medicine of Massachusetts General Hospital (MGH).

Join to view full profile

Dr. Evins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Evins' full profile

Already have an account?

Office
25 Staniford Street
Erich Lindemann Center
Boston, MA 02114
Phone+1 617-912-7800

Fax+1 617-723-3919

Education & Training

Harvard School of Public HealthMPH, Clinical Effectiveness, 2001 - 2002
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1992 - 1995
Childrens National Medical CenterInternship, Transitional Year, 1991 - 1992
Medical University of South CarolinaClass of 1991

Certifications & Licensure

MA State Medical License 1993 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke Start of enrollment: 1998 Aug 01
Completed
Phase 4
Smoking Relapse Prevention in Schizophrenia Start of enrollment: 2006 Apr 01
Completed
Phase 4
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia Start of enrollment: 2001 Jul 01
Completed
Phase 4
Galantamine for Cognition in People With Schizophrenia Start of enrollment: 2004 Jan 01
Completed
Phase 4
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia Start of enrollment: 2005 Apr 01
Completed
Phase 4
The Effects of Nicotine on Cognition in Schizophrenia Start of enrollment: 2004 Apr 01
Completed
Phase 4
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia Start of enrollment: 2007 Mar 01
Completed
Not Applicable
A Comparison of Two Cognitive Batteries in People With Schizophrenia Start of enrollment: 2007 Dec 01
Completed
Not Applicable
A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia Start of enrollment: 2007 Aug 01
Completed
Not Applicable
Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia Start of enrollment: 2007 Dec 01
Terminated
Phase 1
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder Start of enrollment: 2008 Feb 01
Completed
Phase 4
Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence Start of enrollment: 2008 Apr 01
Completed
Phase 3
Cognitive Remediation With D-Cycloserine Start of enrollment: 2011 May 01
Completed
Phase 3
A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence Start of enrollment: 2011 Dec 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Social networks of people with serious mental illness who smoke: potential role in a smoking cessation intervention.
Benjamin P L Meza, Craig E Pollack, Carla Tilchin, Jacky M Jennings, Carl A Latkin
Journal of Mental Health. 2024-12-01
5 citations
Addressing Barriers to Provision of First-Line Pharmacotherapy for Tobacco Use Disorder.
A Eden Evins, Corinne Cather
Psychiatric Services. 2023-04-01
6 citations
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns.
Brenden Tervo-Clemmens, William Schmitt, Grace Wheeler, Megan E Cooke, Randi M Schuster
Drug and Alcohol Dependence. 2023-02-01

Press Mentions

New Age of Legalized Marijuana Calls for New Look at Science, PolicyJune 2nd, 2016
Marijuana and Cannabinoids: A Neuroscience Research SummitMarch 22nd, 2016
Evins Named First Incumbent of the William Cox Family ProfessorshipAugust 22nd, 2014